SBH
COV

Segall Bryant & Hamill’s COVIDIEN PLC COM SHS NEW (IRELAND) COV Stock Holding History

Segall Bryant & Hamill’s Portfolio COV Stock Details COV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-135,050
Closed -$13.8M – 579
2014
Q4 		$13.8M Sell
135,050
-16,231
-11% -$1.56M 0.31% 100
2014
Q3 		$13.1M Buy
151,281
+111,662
+282% +$9.89M 0.3% 106
2014
Q2 		$3.57M Sell
39,619
-5,399
-12% -$404K 0.09% 221
2014
Q1 		$3.32M Sell
45,018
-233
-0.5% -$16.2K 0.08% 230
2013
Q4 		$3.08M Sell
45,251
-607
-1% -$39.5K 0.07% 234
2013
Q3 		$2.79M Sell
45,858
-2,593
-5% -$158K 0.07% 240
2013
Q2 		$2.7M Buy
+48,451
New +$2.8M 0.07% 239

Segall Bryant & Hamill's COV Position: Q1 2015 in Review

Segall Bryant & Hamill sold out of COVIDIEN PLC COM SHS NEW (IRELAND) (COV) in Q1 2015, closing a stake of 135,050 shares — an estimated $13.8M sold.

Segall Bryant & Hamill first reported a position in COV in Q2 2013 and held it in 7 quarters. The position peaked at $13.8M in Q4 2014. 1 fund tracked by Wall St. Rank holds COV as of Q1 2015.

  • Segall Bryant & Hamill reported no remaining COVIDIEN PLC COM SHS NEW (IRELAND) position as of Q1 2015 after selling out during the quarter.
  • Segall Bryant & Hamill sold 135,050 COVIDIEN PLC COM SHS NEW (IRELAND) shares in Q1 2015, an estimated $13.8M.
  • Segall Bryant & Hamill first reported a position in COVIDIEN PLC COM SHS NEW (IRELAND) in Q2 2013 and held it in 7 quarters.
  • Segall Bryant & Hamill's COVIDIEN PLC COM SHS NEW (IRELAND) position peaked at $13.8M in Q4 2014.
  • 1 fund tracked by Wall St. Rank held COVIDIEN PLC COM SHS NEW (IRELAND) as of Q1 2015.

Based on Segall Bryant & Hamill's 13F filing for Q1 2015, filed 14 May 2015.